Marzan, the last acceleration was for Sawston expansion of manual capacity. I’m not certain Flaskwork’s system would be required before Sawston cert., but it might be needed soon after any L approval.
Here is the conundrum they might have already worked through.
1. Results will likely create a great deal more demand.
2. UK will likely need to pay on a cost neutral basis (this does not mean no profit), before NICE does official evaluation, because gofundme on 45 patients per month won’t fly.
3. UK needs to know (be assurred), apparently, flaskworks will be online/cert once demand outstrips manual supply.
Remember, Flaskworks didn’t come up with this technology recently. Shashi Murthy has been developing it since June 2015, and I suspect, even prior to acquisition by NWBO, it has been focused on the exact kind of end to end autologous tumor lysate pulsed DCs would need. In other words, I think the veil has been very thin for many years.
Market Data 
Markets 
AI
